Oropharyngeal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Oropharyngeal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-09-04Clinical Trial Update: Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma [Phase 1, Phase 2]
This clinical trial update notes that the Phase 1/Phase 2 study of a stereotactic boost for oropharyngeal squamous cell carcinoma has been w…
-
CLINICAL_TRIALS other · 2015-04-22Clinical Trial Update: Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma
A clinical trial evaluating breath biomarkers for head and neck squamous cell carcinoma (NCT02156180) is currently suspended.
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers
A completed clinical trial evaluated pharmacogenetic responses to induction chemotherapy across head and neck squamous cell carcinomas of th…
-
CLINICAL_TRIALS withdrawal · 2015-03-20Clinical Trial Update: Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer [Phase 2]
Phase 2 trial evaluating radiation therapy and cisplatin with or without surgery for stage III-IV oropharyngeal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-09-03Clinical Trial Update: Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer [NA]
A clinical trial investigating photodynamic therapy with temoporfin before surgery for recurrent oral cavity and oropharyngeal cancers has b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck
Phase II trial evaluating parotid-gland sparing IMRT for midline head and neck cancers. The study includes patients with oropharyngeal and h…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 clinical trial evaluating sunitinib for patients with recurrent or metastatic head and neck squamous cell carcinoma, with results po…
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating lapatinib in recurrent and/or metastatic head and neck squamous cell carcinoma (including occult primary cases) has…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating the combination of erlotinib and docetaxel in patients with locally advanced, metastatic, or recur…
-
CLINICAL_TRIALS trial_result · 2008-06-24Clinical Trial Update: Phase II Trial of Allovectin-7® for Head and Neck Cancer [Phase 3]
This clinical trial update announces the completion of a Phase 3 study of Allovectin-7 for head and neck cancer, including squamous cell car…
-
CLINICAL_TRIALS research · 2006-10-26Clinical Trial Update: Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma. [Phase 2]
This document provides a Phase 2 clinical trial update of cetuximab with concomitant-boost accelerated radiotherapy for locally advanced oro…